Advocacy
Through advocacy, policy development and public relations, the AANS/CNS Washington Committee and Washington Office work to defend and protect the ability of neurosurgeons to practice medicine freely and help to ensure the continued advancement of the specialty of neurological surgery
Featured Issue Areas
-
Healthcare Competition
The AANS/CNS Drugs and Devices Committee is actively engaged with the Food and Drug Administration (FDA) and other scientific representatives to provide neurosurgical expertise on drugs and devices used to treat patients and foster innovation and safety. These activities include recommending neurosurgeon experts to serve on the FDA Advisory panels, providing input on FDA Guidance Documents and testimony at panel meetings.
-
Graduate Medical Education
To ensure an adequate supply of physicians, organized neurosurgery continues to petition Congress to maintain Medicare’s current financial support of graduate medical education and encourage all other payers to contribute to graduate medical education (GME) programs.
-
Guidelines
The AANS and CNS recognize that clinical practice guidelines are potentially useful tools for improving the quality of clinical patient care. However, the AANS and CNS also assert that these guidelines must be of the highest possible quality in order to limit the potential for unjustified restriction of provider autonomy and flexibility in the pursuit of optimal clinical care
-
Biomedical Research
Diseases that were once a death sentence are now treatable. Given this, the AANS and CNS continue to urge Congress to expand the scope of the current federal policy on medical research and to ensure that appropriate funding is allocated to such programs.
Learn More About the Washington Office
Explore upcoming agenda items, press releases, and other Washington Office initiatives.
